How Finerenone differs from other mineral corticosteroid receptor antagonists

Finerenone (Finerenone) is a new type of mineral corticosteroid receptor antagonist (MRA). It is mainly used to treat patients with chronic kidney disease combined with type 2 diabetes to reduce the risk of renal and cardiovascular events. Compared with traditional MRAsuch as spironolactone (Spironolactone) and eplerenone (Eplerenone), fenelinone exhibits significant differences in pharmacological properties and clinical applications.

Fenelidone is more selective and has strong affinity for mineral corticosteroid receptors, but has less cross-effects on other hormone receptors such as androgen and estrogen receptors. Therefore, its hormone-related side effects such as gynecomastia, menstrual disorders, etc. are significantly reduced. In contrast, spironolactone has a wider range of action targets and more side effects, which limits its widespread clinical use.

Fenelinone has excellent renal and cardiovascular protective effects. Clinical trials have shown that fenelidone can not only effectively reduce proteinuria, but also reduce the incidence of cardiovascular events in patients with chronic kidney disease. This is mainly due to its ability to potently inhibit inflammation and fibrosis, in which traditional MRA has relatively limited efficacy.

Fenelidone has a better safety profile, especially in controlling the risk of hyperkalemia. Although all MRA drugs may cause an increase in serum potassium, fenelinone has smaller fluctuations in potassium levels during clinical use due to its advantages in pharmacokinetics and pharmacodynamics, and is better tolerated by patients. It is especially suitable for patients with reduced renal function.

To sum up, fenelinone, as a new generation of mineral corticosteroid receptor antagonist, has become an important choice for the clinical treatment of chronic kidney disease and related cardiovascular diseases due to its high selectivity, excellent renal and cardioprotective effect and low risk of side effects. Compared with traditional MRA, fenelidone provides patients with a safer and more effective treatment option.

Reference materials:https://www.kerendia.com/

xa0